fluconazole has been researched along with Infant, Newborn, Diseases in 8 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amphotericin B deoxycholate has been favored for many years, but fluconazole has the most data supporting its use in neonatal Candida infections and is often employed for prophylaxis as well as treatment." | 2.49 | Old and new: appropriate dosing for neonatal antifungal drugs in the nursery. ( Benjamin, DK; Ericson, J; Manzoni, P, 2013) |
| "Invasive candidiasis is an important cause of sepsis in extremely low birth weight infants (ELBW, < 1000 g), is often fatal, and frequently results in neurodevelopmental impairment (NDI) among survivors." | 1.48 | Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis. ( Adams-Chapman, I; Autmizguine, J; Benjamin, DK; Cohen-Wolkowiez, M; Cotten, CM; Goldberg, RN; Smith, PB; Stoll, BJ; Tan, S; Wiederhold, N, 2018) |
| "The 8 patients with septicemia caused by Candida haemulonii had similar clinical chariacteristics to those of other neonatal candidemia, such as apnea, fever, abdominal distension, jaundice etc." | 1.43 | [Clinical analysis of 8 cases of neonatal septicemia caused by Candida haemulonii in neonatal intensive care unit]. ( Chen, S; Hu, Y; Huang, X; Jie, Q; Lin, S; Lin, Z; Zhang, H, 2016) |
| " Information was requested on the prophylactic agents used, dosing schedules and duration of therapy." | 1.35 | Antifungal prophylaxis for the prevention of neonatal candidiasis? ( Dempsey, EM; O'Grady, MJ, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Autmizguine, J | 1 |
| Tan, S | 1 |
| Cohen-Wolkowiez, M | 1 |
| Cotten, CM | 1 |
| Wiederhold, N | 1 |
| Goldberg, RN | 1 |
| Adams-Chapman, I | 1 |
| Stoll, BJ | 2 |
| Smith, PB | 2 |
| Benjamin, DK | 3 |
| Camacho-Gonzalez, A | 1 |
| Spearman, PW | 1 |
| Ericson, J | 1 |
| Manzoni, P | 1 |
| Jie, Q | 1 |
| Lin, S | 1 |
| Zhang, H | 1 |
| Hu, Y | 1 |
| Huang, X | 1 |
| Chen, S | 2 |
| Lin, Z | 1 |
| Ericson, JE | 1 |
| Kaufman, DA | 1 |
| Kicklighter, SD | 1 |
| Bhatia, J | 1 |
| Testoni, D | 1 |
| Gao, J | 1 |
| Prather, KO | 1 |
| Chong, PP | 1 |
| Chieng, DC | 1 |
| Low, LY | 1 |
| Hafeez, A | 1 |
| Shamsudin, MN | 1 |
| Seow, HF | 1 |
| Ng, KP | 1 |
| Clerihew, L | 1 |
| Austin, N | 1 |
| McGuire, W | 1 |
| O'Grady, MJ | 1 |
| Dempsey, EM | 1 |
4 reviews available for fluconazole and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Neonatal infectious diseases: evaluation of neonatal sepsis.
Topics: Adaptive Immunity; Anti-Infective Agents; Antibodies, Monoclonal; Antifungal Agents; Bacterial Infec | 2013 |
Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; | 2013 |
Fluconazole Prophylaxis for the Prevention of Candidiasis in Premature Infants: A Meta-analysis Using Patient-level Data.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Candidiasis, Invasive; Female; Fluconazole; Humans; Infan | 2016 |
Systemic antifungal prophylaxis for very low birthweight infants: a systematic review.
Topics: Antifungal Agents; Fluconazole; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Very Low | 2008 |
4 other studies available for fluconazole and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Invasive; Cohort Studies; Drug Resistance, | 2018 |
[Clinical analysis of 8 cases of neonatal septicemia caused by Candida haemulonii in neonatal intensive care unit].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; C-Reactive Protein; Candida; Candidiasis; | 2016 |
Recurrent candidaemia in a neonate with Hirschsprung's disease: fluconazole resistance and genetic relatedness of eight Candida tropicalis isolates.
Topics: Antifungal Agents; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; | 2006 |
Antifungal prophylaxis for the prevention of neonatal candidiasis?
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Newbor | 2008 |